Low DHA and plasmalogens associated with a precise PUFA-rich diet devoid of DHA

Clinical Biochemistry

Volumn 43, Issue 16-17, 2010, Pages 1305-1308

  Glick, Norris R ^a   Fischer, Milton H ^a,b  

^a UNIVERSITY OF WISCONSIN   (United States)

^b Central Wisconsin Center   (United States)

Author keywords

Developmental disabilities; Docosahexaenoic acid; Fatty acids; Gastrostomy feedings; Mental retardation; Plasmalogens

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; PHOSPHOLIPID; PLASMALOGEN; POLYUNSATURATED FATTY ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAT INTAKE; FEMALE; GAS CHROMATOGRAPHY; GASTROSTOMY; HUMAN; LIPID COMPOSITION; MALE; MEMBRANE COMPONENT; NUTRITIONAL SUPPORT; PRIORITY JOURNAL;

ADULT; AGED; DIET; DOCOSAHEXAENOIC ACIDS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOSPHOLIPIDS; PLASMALOGENS;

EID: 77957328233     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.08.021     Document Type: Article

References (23)

1. Glick N., Fischer M. Essential fatty acid-deprived tube-fed adults synthesize arachidonic and docosahexaenoic acids: a pilot analysis of the fatty acid status of people with profound developmental disabilities. Clin Biochem 2008, 41:1019-1021.
2. Jump D. N-3 polyunsaturated fatty acid regulation of hepatic gene transcription. Curr Opin Lipidol 2008, 19:242-247.
3. Chen W., Jump D., Esselman W., Busik J. Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaenoic acid. Invest Ophthalmol Vis Sci 2007, 48:18-26.
4. Thai T., Rodemer C., Jauch A., Hunziker A., Moser A., Gorgas K., et al. Impaired membrane traffic in defective ether lipid biosynthesis. Hum Mol Genet 2001, 10:127-136.
5. Ginsberg L., Xuereb J., Gershfeld N. Membrane instability, plasmalogen content, and Alzheimer's disease. J Neurochem 1998, 70:2533-2538.
6. Han X., Holtzman D., McKeel D.J. Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry. J Neurochem 2001, 77:1168-1180.
7. Wood P., Mankidy R., Ritchie S., Heath D., Wood J., Flax J., et al. Circulating plasmalogen levels and Alzheimer disease assessment scale-cognitive scores in Alzheimer patients. J Psychiatry Neurosci 2010, 35:59-62.
8. Engelmann B. Plasmalogens: targets for oxidants and major lipophilic antioxidants. Biochem Soc Trans 2004, 32:147-150.
9. Harris W. Omega-6 and omega-3 fatty acids: partners in prevention. Curr Opin Clin Nutr Metab Care 2010, 13:125-129.
10. Dietary reference intakes. The essential guide to nutrient requirements 2006, The National Academies Press, Washington, DC, [543 pp.]. J.J. Otten, H.J. Pitzi, L.D. Meyers (Eds.).
11. Simopoulos A., Leaf A., Salem N.J. Workshop on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. J Am Coll Nutr 1999, 18:487-489.
12. Farooqu A., Horrocks L. Plasmalogens, phospholipase a2, and docosahexaenoic acid turnover in brain tissue. J Mol Neurosci 2001, 16:263-272. [discussion 79-84].
13. Goodenowe D., Cook L., Liu J., Lu Y., Jayasinghe D., Ahiahonu P., et al. Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia. J Lipid Res 2007, 48:2485-2498.
14. Brenna J., Salem N.J., Sinclair A., Cunnane S. Alpha-linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids 2009, 80:85-91. International Society for the Study of Fatty Acids and Lipids I.
15. Arterburn L., Hall E., Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 2006, 83:1467S-1476S.
16. Hodson L., Skeaff C., Fielding B. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 2008, 47:348-380.
17. Wassall S., Stillwell W. Polyunsaturated fatty acid-cholesterol interactions: domain formation in membranes. Biochim Biophys Acta 2009, 1788:24-32.
18. Liou Y., King D., Zibrik D., Innis S. Decreasing linoleic acid with constant alpha-linolenic acid in dietary fats increases (n-3) eicosapentaenoic acid in plasma phospholipids in healthy men. J Nutr 2007, 137:945-952.
19. Cho H., Nakamura M., Clarke S. Cloning, expression, and nutritional regulation of the mammalian delta-6 desaturase. J Biol Chem 1999, 274:471-477.
20. Barham J., Edens M., Fonteh A., Johnson M., Easter L., Chilton F. Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans. J Nutr 2000, 130:1925-1931.
21. Warensjö E., Risérus U., Gustafsson I., Mohsen R., Cederholm T., Vessby B. Effects of saturated and unsaturated fatty acids on estimated desaturase activities during a controlled dietary intervention. Nutr Metab Cardiovasc Dis 2008, 18:683-690.
22. Kuratko C., Salem N.J. Biomarkers of DHA status. Prostaglandins Leukot Essent Fatty Acids 2009, 81:111-118.
23. Dagenais G., Tancredi R., Zierler K. Free fatty acid oxidation by forearm muscle at rest, and evidence for an intramuscular lipid pool in the human forearm. J Clin Invest 1976, 58:421-431.